BioSpace News Archive

Joerns Healthcare, a leading manufacturer and provider of patient care products across the care continuum, today announced the appointment of Julie Wilson as the Vice President of Human Resources

The majority of people visiting preoperative testing clinics before an elective surgery do not have an advance directive (AD) in case of surgical complications.

Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a developer, manufacturer and service provider of advanced cell therapies, announces that the United States Food & Drug Administration (FDA) has granted Orphan Drug designation for its Autologous Insulin Producing (AIP) cells as a cell replacement therapy for the treatment of severe hypoglycemia-prone diabetes resulting from total pancreatectomy (TP) due to chronic pancreatitis (CP)

Accolade and EY announced that Rajeev Singh, CEO of Accolade, a personalized advocacy solution for employers and their members, received the Entrepreneur Of The Year® 2019 Award in the Innovator category, Pacific Northwest region.

Pulse Biosciences, Inc. announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 17,750 shares of Pulse Biosciences common stock to three recently hired non-executive employees under the Pulse Biosciences 2017 Inducement Equity Incentive Plan on June 17, 2019.

ADVANZ PHARMA Corp. announced the voting results from its Annual Meeting of Shareholders held on June 17, 2019, in Toronto, Ontario.

Biohaven Pharmaceutical Holding Company Ltd. announced that it has commenced an underwritten public offering of $300 million of its common shares.

Participants include local organizations, entrepreneurs and innovators across healthcare, technology, engineering, art, music, academia and more

Innovent Biologics, Inc. announced that the clinical results of CT103A, the potential best-in-class therapy of fully-human BCMA CAR-T co-developed by Innovent and Nanjing IASO Biotherapeutics, was presented by oral presentation and poster at two of the most prestigious clinical meetings in the worlds of hematology and oncology, the 24th Congress of the European Hematological Society and the American Society of Clinical Oncology Annual Meeting 2019 in Chicago Illinois.

Crescita Therapeutics Inc. announced that it intends to make a normal course issuer bid for a portion of its common shares as appropriate opportunities arise from time to time.